Rituxmab Versus IL-6 in Treating ILD

Conditions:   Interstitial Lung Disease;   Scleroderma Interventions:   Drug: Rituximab;   Drug: IL6 inhibitor Sponsor:   Assiut University Completed

Source: ClinicalTrials.gov - July 27, 2023 Category: Research Source Type: clinical trials